TG Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €1.48B +18.9% €608.41M +36.5% 41.2% +0.053 pp N/A N/A
    (estimated) €1.24B +38.2% €445.69M +48.3% 35.9% +0.024 pp N/A N/A
    (estimated) €898.64M +23.6% €300.61M +22.4% 33.5% -0.0033 pp €250.35M +43.4% 27.9% +0.038 pp
    (estimated) €726.93M +45.5% €245.55M +137.5% 33.8% +0.13 pp €174.62M +11.8% 24.0% -0.073 pp
    (estimated) €499.53M +78.0% €103.39M +418.4% 20.7% +0.14 pp €156.23M -552.6% 31.3% +0.44 pp
    €280.62M +40.8% €19.94M +84.5% 7.1% +0.017 pp -€34.52M +28.8% -12.3% +0.011 pp
    €199.30M +8,290.0% €10.81M -106.2% 5.4% +73 pp -€26.79M -82.2% -13.4% +63 pp
    €2.38M -58.4% -€173.86M -42.7% -7,318.9% -20 pp -€150.25M -40.3% -6,325.2% -19 pp
    €5.71M +4,300.7% -€303.27M +24.4% -5,315.5% +1.8K pp -€251.82M +37.9% -4,413.7% +1.4K pp
    €129.65K +0.0% -€243.84M +59.4% -188,077.6% -700 pp -€182.66M +61.4% -140,888.2% -540 pp
    €129.65K +0.0% -€152.97M +3.4% -117,991.4% -39 pp -€113.17M +3.0% -87,286.2% -25 pp
    €129.65K -0.3% -€147.97M +46.4% -114,132.9% -360 pp -€109.89M +37.4% -84,759.9% -230 pp
    €129.97K +0.0% -€101.05M +51.4% -77,749.9% -260 pp -€79.97M +53.1% -61,530.9% -210 pp
    €129.97K +0.0% -€66.75M +24.3% -51,353.4% -100 pp -€52.24M +37.2% -40,193.6% -110 pp
    €129.97K +0.0% -€53.69M +12.8% -41,310.0% -47 pp -€38.08M +27.4% -29,300.3% -63 pp
    €129.97K +0.0% -€47.58M +172.4% -36,606.5% -230 pp -€29.89M +223.9% -22,995.9% -160 pp
    €129.97K +700.0% -€17.47M +13.3% -13,438.8% +810 pp -€9.23M +108.6% -7,099.7% +200 pp
    €16.25K +∞% -€15.42M +2,018.5% -94,879.9% -950 pp -€4.42M +5,890.7% -27,228.9% -270 pp
    €0.00 +NaN% -€727.63K -236.8% N/A -€73.85K -95.6% N/A
    €0.00 +NaN% €531.94K -122.3% N/A -€1.68M +87.4% N/A
    €0.00 +NaN% -€2.38M -34.6% N/A -€895.43K -76.3% N/A
    €0.00 +NaN% -€3.64M -64.5% N/A -€3.78M -56.6% N/A
    €0.00 +NaN% -€10.26M +24.1% N/A -€8.72M +32.5% N/A
    €0.00 +NaN% -€8.27M -49.3% N/A -€6.58M +24.3% N/A
    €0.00 +NaN% -€16.33M +224.6% N/A -€5.29M +11.8% N/A
    €0.00 +NaN% -€5.03M -1.1% N/A -€4.74M +61.2% N/A
    €0.00 -100.0% -€5.08M +285.3% N/A -€2.94M +141.4% N/A
    €426.48K -81.6% -€1.32M -10.8% -309.4% -2.5 pp -€1.22M -67.3% -285.4% -1.2 pp
    €2.31M -49.4% -€1.48M -70.1% -64.0% +0.44 pp -€3.72M +344.8% -161.0% -1.4 pp
    €4.57M +346.6% -€4.95M +141.8% -108.3% +0.92 pp -€837.34K -55.4% -18.3% +1.7 pp
    €1.02M -60.0% -€2.05M -14.3% -200.0% -1.1 pp -€1.88M -8.3% -183.3% -1.0 pp
    €2.56M +2,900.0% -€2.39M -46.2% -93.3% +51 pp -€2.05M -38.5% -80.0% +38 pp
    €85.30K +0.0% -€4.44M +44.4% -5,200.0% -16 pp -€3.33M +0.0% -3,900.0% +0.0 pp
    €85.30K -€3.07M -3,600.0% -€3.33M -3,900.0%

    Notifications